Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Most Accessed Articles

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

Volume: 18   Issue: 4
Pp: 306-327
Heena Singla, Anjana Munshi*, Raja Paramjit Singh Banipal and Vinod Kumar*
DOI: 10.2174/1568009617666170623122213

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives open access plus

Volume: 13   Issue: 3
Pp: 326-346
Ziyad Binkhathlan and Afsaneh Lavasanifar
DOI: 10.2174/15680096113139990076

Tunneling Nanotubes: A Versatile Target for Cancer Therapy

Volume: 18   Issue: 6
Pp: 514-521
Pragyaparamita Sahu, Soumya Ranjan Jena and Luna Samanta*
DOI: 10.2174/1568009618666171129222637

Towards Prevention of Ovarian Cancer

Volume: 18   Issue: 6
Pp: 522-537
Aus Tariq Ali*
DOI: 10.2174/1568009618666180102103008

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation promotion: free to download

Volume: 3   Issue: 1
Pp: 1-19
R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden
DOI: 10.2174/1568009033333754

Electrochemotherapy as First Line Cancer Treatment: Experiences from Veterinary Medicine in Developing Novel Protocols promotion: free to download

Volume: 16   Issue: 1
Pp: 43-52
E. P. Spugnini, T. Azzarito, S. Fais, M. Fanciulli and A. Baldi
DOI: 10.2174/156800961601151218155340

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer open access plus

Volume: 15   Issue: 8
Pp: 665-683
Otília Menyhart, Libero Santarpia and Balazs Gyorffy
DOI: 10.2174/156800961508151001101742

The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations

Volume: 18   Issue: 4
Pp: 355-364
Dearbhaile C. Collins, Maxime Chenard-Poirier and Juanita S. Lopez*
DOI: 10.2174/1568009617666170927114440

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy promotion: free to download

Volume: 9   Issue: 1
Pp: 32-71
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento
DOI: 10.2174/156800909787314002

Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

Volume: 17   Issue: 9
Pp: 846-857
Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*
DOI: 10.2174/1568009617666170214104426